Each summer, the Aspen Ideas Festival becomes a rare gathering place where medicine, culture, and public life briefly converge — and this year, Mount Sinai Health System arrives not merely as a participant but as an architect of the conversation. From June 22 through July 1, the institution will lead discussions on some of the most consequential questions in modern health: how young people build psychological resilience, how science might extend not just life but the quality of living, and how artificial intelligence and psychedelics are quietly reshaping what medicine can do. In placing its r
Mount Sinai Leads Aspen Festival Discussions on Youth Mental Health and Longevity Science
Sports and creative arts can serve as powerful, evidence-based interventions
Why does Mount Sinai care so much about being at Aspen? It's a festival, not a medical conference.
Because Aspen gathers the people who shape policy, business, and culture—not just medicine. If you want to influence how healthcare evolves, you need to be in the room where those conversations happen.
The youth mental health panel is interesting. Why pair a quarterback with psychiatrists?
Because the research shows that sports and creative expression actually work as interventions. But most young people won't go to a clinic asking for help. They'll show up to practice. So the panel is asking: how do we scale what's already working in communities?
And the healthspan panel—that's different from longevity, right?
Exactly. Longevity is just living longer. Healthspan is living longer while staying strong, sharp, independent. The science is shifting from extension to quality.
The psychedelics panel seems bold for a major health system.
It is. But Mount Sinai has been researching this seriously for years. They're not endorsing anything—they're asking whether the evidence supports clinical use. That's the responsible position.
What's the business angle here?
Reputation, partly. But also: these are the health challenges that will define the next decade. Being first to shape the conversation around them matters. And the screening experience—that's not charity. It's also a way to gather data and build relationships with influential people.
So this is about influence as much as medicine?
It's about recognizing that medicine doesn't happen in isolation. The future of healthcare gets decided in rooms like Aspen, by people who aren't doctors. Mount Sinai is making sure their voice is heard.
El Pulso
- Youth mental health has reached a scale that clinical settings alone cannot absorb, and Mount Sinai is betting that sports, art, and community — not just therapy — are legitimate medical interventions.
- The tension between living longer and living well is driving a new generation of genomic and imaging science, with Mount Sinai specialists arguing that healthspan, not just lifespan, must become medicine's true measure.
- Artificial intelligence, psychedelic-assisted therapy, and the rising cost of care are no longer fringe topics — they are arriving on the main stage at Aspen, carried by physicians who treat patients with them daily.
- Mount Sinai is the only institution sponsoring both the main festival and its health track, a deliberate positioning that reflects its ambition to be seen not just as a hospital system but as a shaper of medicine's future direction.
- Free health screenings — from retinal scans estimating biological age to grip strength assessments — will run throughout the festival, bringing the institution's clinical tools directly to the public in an unusual act of open access.
Each summer, the Aspen Ideas Festival becomes a rare gathering place where medicine, culture, and public life briefly converge — and this year, Mount Sinai Health System arrives not merely as a participant but as an architect of the conversation. From June 22 through July 1, the institution will lead discussions on some of the most consequential questions in modern health: how young people build psychological resilience, how science might extend not just life but the quality of living, and how artificial intelligence and psychedelics are quietly reshaping what medicine can do. In placing its researchers, clinicians, and leaders at the center of these debates, Mount Sinai signals that the future of health will be shaped as much in public dialogue as in the laboratory.
Mount Sinai Health System is arriving at the 2026 Aspen Ideas Festival not as a sponsor in the background but as a central voice in conversations about where medicine is heading. From June 22 through July 1 in Aspen, Colorado, the institution will lead multiple panel discussions and operate a public health screening experience — the only health system underwriting both the main festival and its companion health-focused track.
The opening panel, on June 22, approaches youth mental health from an unexpected direction. CEO Brendan Carr will moderate a conversation featuring Super Bowl-winning quarterback Russell Wilson and co-founder of the Second Round Foundation Sandra Brunson, alongside Mount Sinai physicians. The discussion centers on how athletic participation, creative arts, and structured community programs can function as evidence-based tools for building psychological resilience in young people — and how these interventions, long present in locker rooms and community centers, are being adapted for clinical settings.
A week later, on June 29, Carr will moderate a second major panel on the science of healthy aging, bringing together four Icahn School of Medicine specialists in neurology, genomics, cardiology, and biomedical engineering. Their focus will be on translating advances in genomics, imaging, and continuous health monitoring into clinical practice — with the goal of adding not just years to life, but years of strength, clarity, and independence.
Mount Sinai experts will also appear on four additional panels covering healthcare cost reduction, the reimagining of medical education, AI in clinical decision-making, and the growing clinical potential of psychedelic-assisted therapy. Rachel Yehuda, who directs Mount Sinai's psychedelic research center, will represent the institution on that last frontier.
Throughout the festival, attendees can book free screenings at The Grove at Aspen Meadows — dermatologic checks, body composition scans, grip strength tests, and retinal scans that estimate biological age. The screenings run the full length of the festival, with reservations having opened June 16.
For Mount Sinai — one of the largest academic medical centers in the New York area, with nearly 48,000 employees across seven hospitals — Aspen represents something more than a conference. It is a deliberate effort to shape the public conversation about medicine's next chapter, from how adolescents learn to cope to how science might redefine what it means to grow old well.
Mount Sinai Health System is bringing its research and clinical leadership to the Aspen Ideas Festival this summer, hosting a series of conversations about how medicine is changing the way we think about youth mental health, aging well, and the role of technology in care. From June 22 through July 1 in Aspen, Colorado, the health system will sponsor multiple panel discussions and host a public health screening experience, positioning itself as the only institution underwriting both the main Aspen Ideas Festival and its companion health-focused track.
The opening event, on Monday, June 22, will tackle youth mental health through an unexpected lens: sports, creative expression, and community engagement. Mount Sinai's CEO Brendan Carr will moderate a panel that includes Russell Wilson, the Super Bowl-winning quarterback and founder of the Why Not You Foundation, alongside Sandra Brunson, co-founder of the Second Round Foundation, and several Mount Sinai physicians. The conversation will examine how athletic participation, creative arts, and structured community programs can serve as evidence-based tools to build psychological resilience in young people, reduce stress, and create what the panelists call psychological safety. The discussion will also explore how Mount Sinai and its partners are taking these interventions—traditionally found in locker rooms and community centers—and adapting them for clinical settings, meeting adolescents where they already spend time.
A week later, on June 29, Carr will moderate a second major panel focused on the science of healthy aging. This session will bring together four specialists from the Icahn School of Medicine at Mount Sinai: a neurologist studying molecular biology, a geneticist leading the Institute for Genomic Health, a cardiologist focused on heart failure research, and the founding director of the health system's biomedical engineering institute. Together, they will discuss how advances in genomics, imaging, and continuous health monitoring are being translated into clinical practice—not simply to extend how long people live, but to add years of strength, mental clarity, and independence. The panelists will explore how these scientific discoveries can power more personalized treatment plans and smarter clinical trials.
Beyond these flagship events, Mount Sinai experts will participate in four additional festival panels. The health system's CEO will join a discussion on reducing healthcare costs. Kenneth Davis, who led Mount Sinai as CEO for two decades before stepping down in 2024 and now serves as executive vice chairman, will participate in a session on reimagining medical education. A neurologist will speak on artificial intelligence and medical decision-making. And Rachel Yehuda, director of Mount Sinai's research center focused on psychedelic-assisted therapy, will participate in a panel examining the clinical potential and readiness of psychedelics in medicine.
In addition to the formal panels, Mount Sinai will operate a health screening experience throughout the festival at The Grove at Aspen Meadows. Attendees can book free dermatologic screenings, body composition scans, grip strength assessments, and retinal scans that estimate biological age. The screenings run from June 22 through July 1, and reservations opened on June 16.
The festival programming reflects Mount Sinai's stated priorities: how collaboration between researchers, clinicians, and community organizations can improve health outcomes; the role of artificial intelligence and data in personalizing care; and how the next generation of physicians should be trained. Carr, in a statement, emphasized that Aspen provides a rare gathering of health leaders and innovators, and that Mount Sinai sees the festival as an opportunity to shape conversations about the future of medicine. The health system, one of the largest academic medical centers in the New York metropolitan area with nearly 48,000 employees across seven hospitals and more than 400 outpatient practices, has positioned itself as a thought leader on these emerging frontiers—from how young people build mental resilience to how we might extend not just lifespan, but the years we spend healthy and independent.
Citas Notables
Mount Sinai's thought leaders will engage in timely conversations on some of the most important issues shaping the future of health and medicine. This year's discussions will explore innovative approaches to healthy aging, longevity, mental health, personalized care, healthcare costs, the use of psychedelics in healthcare, artificial intelligence, and the future of medical education.— Brendan G. Carr, MD, CEO of Mount Sinai Health System